Amgen stock leans on its pipeline. Investors track a U.S. biotech giant.

Amgen stock leans on its pipeline. Investors track a U.S. biotech giant.  AD HOC NEWS

Summary aggregated from AD HOC NEWS's public RSS feed. The full reporting belongs to AD HOC NEWS — please read it on their site.